vision/eye
• about a 90% reduction in dopamine levels in the retina
• L-DOPA treatment rescues the visual defects
|
• overall light-adapted b-wave amplitudes are reduced and the amplitude of the day/night rhythm is damped compared to controls in a light-adapted electroretinographic assay
• on day 2 in constant darkness, circadian regulation of the light-adapted electroretinographic response is abolished
|
• optokinetic tracking indicates a decrease in contrast sensitivity
• visual acuity is reduced
|
homeostasis/metabolism
• about a 90% reduction in the retina
• however, dopamine levels in the brain are preserved
|